StockWatch
·
Medicinal Chemicals & Botanical Products
BuybackJun 9, 2026, 08:11 AM

Trulieve Authorizes $50M Share Repurchase Program

AI Summary

Trulieve Cannabis Corp. announced that its Board of Directors authorized a share repurchase program. The company is permitted to repurchase up to the lesser of $50 million in aggregate value or 8,495,038 subordinate voting shares, which constitutes 5% of its outstanding shares as of June 8, 2026. This program will extend over a 12-month period and is slated to expire on June 16, 2027. CEO Kim Rivers highlighted that the program underscores confidence in the business's long-term value and a disciplined approach to capital allocation, aiming to deliver value to shareholders.

Key Highlights

  • Trulieve's Board of Directors authorized a share repurchase program.
  • The company may repurchase up to $50 million in aggregate value.
  • Alternatively, up to 8,495,038 subordinate voting shares can be repurchased.
  • This represents 5% of the company's issued and outstanding subordinate voting shares as of June 8, 2026.
  • The program will be executed over a 12-month period.
  • The repurchase program is set to expire on June 16, 2027.
  • All subordinate voting shares purchased under the program will be cancelled.
  • CEO Kim Rivers stated the program reflects confidence in long-term value and disciplined capital allocation.